Piper Sandler Remains a Buy on NeoGenomics (NEO)
Piper Sandler analyst David Westenberg maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $18.00.
Piper Sandler Remains a Buy on Alnylam Pharma (ALNY)
In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...
Why Nvidia's stock looks good to these analysts despite earnings jitters
Nvidia Corp.'s stock still looks good to many Wall Street analysts ahead of the artificial-intelligence chip maker's earnings Wednesday, even though the company isn't expected to report the same level ...
Budget resolution will get through the House, says Piper Sandler's Andy Laperriere
Andy Laperriere, Piper Sandler head of U.S. policy, joins 'The Exchange' to discuss the questions around the budget ...
Nvidia's Next AI Boom? Wall Street Thinks This Stock Is About to Explode
Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...
Wall Street Stays Bullish on Nvidia as Blackwell Demand Surges
Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...
Nvidia in focus as Evercore, Piper Sandler praise ahead of Q4 results
Nvidia (NASDAQ:NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...